Welcome to our dedicated page for Fluidra Unsponso news (Ticker: FLDAY), a resource for investors and traders seeking the latest updates and insights on Fluidra Unsponso stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Fluidra Unsponso's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Fluidra Unsponso's position in the market.
Fluidra has acquired Taylor Water Technologies for $78 million, a significant move to enhance Fluidra's offerings in the pool and wellness sector. Taylor, renowned for its water-testing solutions, generated $26 million in sales over the past year, with an EBITDA of $8.5 million. The acquisition is expected to be cash EPS accretive for Fluidra in 2021, strengthening its innovation capabilities and market position in North America and beyond. Taylor will maintain its operational independence and continue to be led by its current CEO, Stephen Heard.
Fluidra reported third-quarter results showing a strong 49% increase in sales to
Fluidra has acquired S.R. Smith, a US-based manufacturer specializing in pool deck equipment and accessories, for $240 million. This acquisition enhances Fluidra's position in both the commercial and residential pool markets, expected to be cash EPS accretive from the start. The deal is projected to raise Fluidra's 2021 sales growth guidance from 35-40% to 37-42%, with cash EPS growth increasing from 80-90% to 83-93%. S.R. Smith will continue to operate independently while contributing positively to Fluidra's overall product delivery capability.